Sort
50,496 grants matching “lung cancer”
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53
$455,018Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Vulnerability of SCLC based on bi-allelic genetic inactivation of RB1 and TP53
$455,018Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2020 · CA
PLCO EEMS and Extended Follow Up
$454,981Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granules
$454,969Trever G Bivona · University Of California, San Francisco · R01 · FY2019 · CA
Translational control of the fibroblast phenotype in IPF
$454,956Peter B Bitterman · University Of Minnesota · P01 · FY2013 · HL
USING RANDOM RISK TO MOTIVATE SMOKING REDUCTION
$454,937Oregon Research Institute · R01 · FY2000 · CA
Context dependent tumor suppression
$454,922David Feldser · University Of Pennsylvania · R01 · FY2025 · CA
Context dependent tumor suppression
$454,922David Feldser · University Of Pennsylvania · R01 · FY2024 · CA
Dissemination and implementation of a corrective intervention to improve mediasti
$454,797Raymond U Osarogiagbon · University Of Memphis · R01 · FY2014 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$454,783Markus Schober · New York University School Of Medicine · R01 · FY2023 · CA
Cancer Bioinformatics Services
$454,743Riyue Bao · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
$454,712Karen Champagne Glass · Albany College Of Pharmacy · R01 · FY2018 · GM
Multiscale Nanotechnologies for Comprehensive Assessment of Lung Cancer in Blood
$454,574Shan X. Wang · Stanford University · U54 · FY2015 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$454,539Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
$454,498Duke University · U01 · FY2003 · CA
LKB1/AMPK Signaling and Peutz-Jeghers Syndrome
$454,494Lewis C Cantley · Brigham And Women'S Hospital · P01 · FY2011 · CA
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
$454,476Adam O Goldstein · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS
$454,425Paul Joseph Brennan · International Agency For Res On Cancer · R01 · FY2008 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$454,400David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Behavioral Smoking Cessation Treatment for People Living with HIV/AIDS
$454,307David M Ledgerwood · Wayne State University · R01 · FY2013 · DA
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$454,280Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
$454,228Damon J. Vidrine · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Clustered semi-competing risks analysis in quality of end-of-life care studies
$454,222Sebastien Haneuse · Harvard School Of Public Health · R01 · FY2015 · CA
Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer
$454,179Ming You · Medical College Of Wisconsin · R01 · FY2011 · CA
Novel therapy targeting refractory colon cancer
$454,126Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA